RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,064 | -83.9% | 17,511 | -60.7% | 0.00% | – |
| Q3 2022 | $19,000 | -92.0% | 44,521 | -84.0% | 0.00% | – |
| Q2 2022 | $238,000 | -88.8% | 278,908 | -27.5% | 0.00% | – |
| Q1 2022 | $2,120,000 | -52.7% | 384,753 | -16.9% | 0.00% | -100.0% |
| Q4 2021 | $4,480,000 | -42.1% | 462,841 | +7.0% | 0.00% | 0.0% |
| Q3 2021 | $7,734,000 | +90.9% | 432,619 | +160.7% | 0.00% | 0.0% |
| Q2 2021 | $4,051,000 | +59.0% | 165,960 | +72.6% | 0.00% | 0.0% |
| Q1 2021 | $2,548,000 | +218.1% | 96,151 | -8.9% | 0.00% | – |
| Q4 2020 | $801,000 | +10.6% | 105,505 | -27.0% | 0.00% | – |
| Q3 2020 | $724,000 | +0.8% | 144,595 | +20.5% | 0.00% | – |
| Q2 2020 | $718,000 | +63.2% | 119,997 | +21.5% | 0.00% | – |
| Q1 2020 | $440,000 | -49.5% | 98,777 | +7.8% | 0.00% | – |
| Q4 2019 | $871,000 | +65.6% | 91,610 | +36.7% | 0.00% | – |
| Q3 2019 | $526,000 | -46.5% | 67,021 | +7.2% | 0.00% | – |
| Q2 2019 | $984,000 | +6.1% | 62,535 | +22.1% | 0.00% | – |
| Q1 2019 | $927,000 | +60.9% | 51,205 | +43.0% | 0.00% | – |
| Q4 2018 | $576,000 | – | 35,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |